Unified Investment Management’s Akebia Therapeutics AKBA Stock Holding History

Unified Investment Management’s Portfolio AKBA Stock Details AKBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16K	Sell	14,000 -4,000	-22%	-$4.76K	0.01%	145
2026 Q1	$25K	Hold	18,000	–	–	0.03%	134
2025 Q4	$29K	Hold	18,000	–	–	0.03%	137
2025 Q3	$49.1K	Buy	+18,000	New	+$59.9K	0.05%	134
2025 Q2	–	Sell	-17,000	Closed	-$32.6K	–	126
2025 Q1	$32.6K	Buy	17,000 +5,500	+48%	+$11.2K	0.04%	116
2024 Q4	$21.9K	Buy	+11,500	New	+$20K	0.02%	111

Other funds holding AKBA

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

AHL

Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

PWP

Parkwoods Wealth Partners Syracuse, New York $622M AUM 24.36% 1-Year Est. Return

OBWG

Onyx Bridge Wealth Group Tarrytown, New York $1.11B AUM 24.65% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Unified Investment Management's AKBA Position: Q2 2026 in Review

Unified Investment Management reduced its Akebia Therapeutics (AKBA) stake by 22% in Q2 2026, selling an estimated $4.76K and leaving 14,000 shares worth $16K. The position accounts for 0.01% of the portfolio, ranked #145.

Unified Investment Management first reported a position in AKBA in Q4 2024 and has held it in 6 quarters since. The position peaked at $49.1K in Q3 2025. 30 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

Unified Investment Management held 14,000 shares of Akebia Therapeutics worth $16K as of Q2 2026.
Unified Investment Management sold 4,000 Akebia Therapeutics shares in Q2 2026, an estimated $4.76K.
Akebia Therapeutics made up 0.01% of Unified Investment Management's portfolio in Q2 2026, its #145 holding.
Unified Investment Management first reported a position in Akebia Therapeutics in Q4 2024 and has held it in 6 quarters since.
Unified Investment Management's Akebia Therapeutics position peaked at $49.1K in Q3 2025.
30 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on Unified Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.